New-onset pemphigus foliaceus following SARS-CoV-2 infection and unmasking multiple sclerosis: A case report.
Fatemeh MohagheghParvaneh HatamiArezoo RefaghatMohammadjavad MehdizadehZeinab AryanianNessa Aghazadeh MohandesiZeinab Mohseni AfsharPublished in: Clinical case reports (2022)
Development of pemphigus foliaceus (PF) following SARS-CoV-2 infection has only been reported in one patient who had received Bamlanivimab and thus might be considered as a drug-induced case of PF. Here, we reported the first case of PF arising solely after COVID infection without taking any culprit drug.